$$\rightleftharpoonup{xx}$$
$$\longleftharp{xx}$$,
$$\longrightharp{xx}$$,
Significance of the Technique with Respect to Existing Methods
This procedure has been designed to screen for in vivo activity of compounds in transgenic mouse models of β-amyloidosis and tauopathy. The staged approach employed here ensures detection of efficacious compounds in cognitive domains relevant to AD3. Moreover, the approach detailed here uses behavioral tests that have clearly defined endpoints, easily implementable quality control checks, can be run in a moderate throughput format, and require little intervention from the investigator. These characteristics result in assays that exhibit good reproducibility within animals and across cohorts, which results in low intra- and inter-assay variance and effect sizes (2 ≤f ≤6) that are robust enough to support behavioral profiling in a drug discovery environment.
Critical Steps within the Protocol
Many mouse models in use for AD drug discovery exhibit behaviors consistent with heightened anxiety and aggression. This makes handling habituation essential for performing any of the behavioral tests described here. As these tests rely on unmotivated behaviors, rough handling by the investigator due to a hyperactive and anxious or aggressive mouse can significantly influence performance. Heightened anxiety could result in failure to perform the task, reducing the overall power of the test. Moreover, light levels in the arena are essential for facilitating the spontaneous locomotion needed for each test. Bright light tends to increase anxiety and suppress locomotion in rodents, therefore care should be taken to adjust ambient light levels to 30-35 lux in the arena.
Another critical aspect of the procedure is minimization of strong environmental cues that would interfere with an animal's ability to perform the tasks. Cleaning of the arena and objects in between runs is essential as mice are attracted to novel scents in the environment. Failure to thoroughly clean the arena and objects could result in skewing spontaneous activity of the mouse and masking true cognitive performance. Investigators should also minimize use of personal hygiene products and colognes/perfumes when performing these procedures. Lastly, rodents exhibit robust diurnal and circadian changes in many overt behaviors20 including learning and memory21. Therefore, to minimize variance due to diurnal rhythms in basal behaviors and cognitive performance, all tests should be done at the same time of day across cohorts and studies.
Further, specifically with regard to novel object recognition, the delay interval between sample and test phase, and the selection and placement of objects in the environment are critical parameters. Memory exists in 3 distinct forms: short term memory (STM), intermediate term memory (ITM) and long term memory (LTM)22,23. Changing the interval between sample and test phases from minutes (STM) to hours (ITM) or days (LTM) will change the type of memory tested by the procedure12. Moreover, prior to running the novel object recognition test, many objects should be screened in a test cohort of mice for potential biases in exploration. An object that is excessively attractive or repulsive to the test cohort cannot be used when assessing novel object recognition. Ideally all objects that will be employed in the test, when placed into an arena, will elicit equal exploration times from a naïve cohort of mice. Inadequate testing and optimization of objects can significantly reduce the power of novel object recognition.
Modifications and Troubleshooting
There are several factors that could increase the apparent variability in the cognitive tests described here. Many mouse models of AD exhibit hyperdynamic locomotion3 which can mask or alter behaviors measured as the cognitive endpoint. Moreover, there is growing evidence that sex24,25,26 and even maternal genotype27 can influence development and progression of neuropathology and cognitive phenotypes in AD mouse models. Unexpected variability or failure to implement a behavioral task could be due to any of these factors. When first implementing a particular behavioral test, results should always be stratified by sex, age and if applicable, maternal genotype. Furthermore, the quality checks outlined in this procedure should always be performed to ensure that hyperactivity or other stereotyped behaviors are not interfering with quantification of cognitive endpoints.
Environment can also influence the spontaneous exploratory behavior of rodents. Scents or sounds that are undetectable to researchers could attract or repel mice, skewing results of cognitive tests that rely on spontaneous behavior. When initially establishing Y-maze or novel object recognition, performance of the control measures to ensure that there are no positional biases in exploration of objects and/or the environment is essential. If positional biases are observed then investigators must thoroughly scrutinize the environment and potentially adjust lighting, arena placement, location of testing room relative to other rooms in the facility (i.e., not near a high traffick area or heavy equipment) and arena cleaning procedures.
Habituation to the testing environment is key to achieving optimal performance in the novel object recognition test. For example, low total exploration times may be due to inadequate habituation. As an alternative to the procedures outlined here for handling (Section 2) and arena (Section 4.2) habituation, habituation to handling and the test environment can be performed as 3, 5 min sessions per day for 2 consecutive days.
Limitations of the Technique
As with any procedure, these behavioral tests have limitations. These procedures have been employed because they test function of various cortical regions and hippocampus. If the mouse model does not exhibit functional deficits in brain regions probed by these tests, then these techniques will not be useful. Moreover, we have chosen cognitive tests that probe short-term memory. If the mechanism of action of the compound under preclinical assessment is not expected to affect short-term memory then these procedures should be modified accordingly (i.e., increasing the sample-test phase interval to test long-term memory). Lastly, these tests use unmotivated behaviors. Therefore, if a mouse model is excessively hyperactive or displays other stereotyped behaviors that prevent exploration of the environment then these procedures might not be optimal. As an alternative, one could use fear conditioning for Tg2576 or other β-amyloidosis mouse models, or the spatial water maze for rTg4510 or other mouse models of tauopathy3.
Future Applications
Once these procedures have been successfully adopted in the lab, several modifications or extensions can be made to assess additional cognitive and functional motor measures. For example, changing the novel object recognition task to determine if a mouse can recognize a change in placement of an object13. Alternatively, instead of using objects, one could use other mice and implement a test of social recognition. With respect to limb clasping and motor function, one could supplement that test with the wire hang and/or grip strength tests. The tests detailed in this method form a solid base to screen for compounds that have in vivo efficacy in translational mouse models for AD, and can be adapted or modified in many ways to best interrogate a particular mouse model or meet the needs of a unique drug discovery program.